A detailed history of City State Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, City State Bank holds 150 shares of AMPH stock, worth $6,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Previous 150 -0.0%
Holding current value
$6,819
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$42.85 - $63.45 $6,427 - $9,517
150 New
150 $7,000
Q3 2023

Oct 16, 2023

BUY
$45.51 - $65.0 $4,551 - $6,500
100 New
100 $5,000
Q2 2022

Aug 22, 2022

SELL
$29.79 - $42.29 $1,489 - $2,114
-50 Reduced 33.33%
100 $3,000
Q4 2021

Mar 11, 2022

BUY
$18.14 - $23.29 $2,721 - $3,493
150 New
150 $4,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.23B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.